These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
848 related articles for article (PubMed ID: 26086860)
1. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist. Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker. Walker MJA; Hayes ES; Saint DA; Adaikan G; Abraham S; Goldin AL; Beatch GN; MacLeod BA; Wall RA; Pugsley MK Biomed Pharmacother; 2018 Oct; 106():510-522. PubMed ID: 29990839 [TBL] [Abstract][Full Text] [Related]
3. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat. Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491 [TBL] [Abstract][Full Text] [Related]
4. Ventricular arrhythmia incidence in the rat is reduced by naloxone. Pugsley MK; Hayes ES; Wang WQ; Walker MJ Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674 [TBL] [Abstract][Full Text] [Related]
5. Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289. Pugsley MK; Saint DA; Penz MP; Walker MJ Br J Pharmacol; 1993 Dec; 110(4):1579-85. PubMed ID: 8306104 [TBL] [Abstract][Full Text] [Related]
7. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade. Pugsley MK; Hayes ES; Saint DA; Walker MJA Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of physiological late Na El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840 [TBL] [Abstract][Full Text] [Related]
9. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Chen WP; Su MJ; Hung LM Eur J Pharmacol; 2007 Jan; 554(2-3):196-204. PubMed ID: 17107672 [TBL] [Abstract][Full Text] [Related]
10. The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction. Xing Y; Chen J; Wang J; Gao Y; Niu W; Zhao M; Zhu H; Guo L; Lu P; Wang S J Ethnopharmacol; 2012 Jun; 141(2):674-84. PubMed ID: 21924334 [TBL] [Abstract][Full Text] [Related]
11. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations. Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological activation of IKr impairs conduction in guinea pig hearts. Larsen AP; Olesen SP; Grunnet M; Poelzing S J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495 [TBL] [Abstract][Full Text] [Related]
13. Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure. Tang HF; Wu SL; Deng CY; Zhang WC; Kuang SJ Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):714-9. PubMed ID: 17600546 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of late Na+ current, a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats. Chi L; Belardinelli L; Zeng A; Hirakawa R; Rajamani S; Ling H; Dhalla AK Am J Physiol Heart Circ Physiol; 2016 May; 310(10):H1313-20. PubMed ID: 26993228 [TBL] [Abstract][Full Text] [Related]
15. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. Yu XC; Wang HX; Pei JM; Wong TM J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart. Cheng L; Ma S; Wei LX; Guo HT; Huang LY; Bi H; Fan R; Li J; Liu YL; Wang YM; Sun X; Zhang QY; Yu SQ; Yi DH; Ma XL; Pei JM Heart Vessels; 2007 Sep; 22(5):335-44. PubMed ID: 17879026 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge. Veeraraghavan R; Poelzing S Cardiovasc Res; 2008 Mar; 77(4):749-56. PubMed ID: 18056761 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Pugsley MK; Penz WP; Walker MJ; Wong TM Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979 [TBL] [Abstract][Full Text] [Related]
19. The cardiac electrophysiological effects of sparteine and its analogue BRB-I-28 in the rat. Pugsley MK; Saint DA; Hayes E; Berlin KD; Walker MJ Eur J Pharmacol; 1995 Dec; 294(1):319-27. PubMed ID: 8788447 [TBL] [Abstract][Full Text] [Related]
20. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine. Pugsley MK; Walker MJ; Saint DA Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]